Biopharmaceutical Market OverviewBiopharmaceuticals are medical drugs produced using biotechnology. They are proteins, nucleic acids used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native biological source. Demand for biopharmaceuticals has been rising significantly over the last few years. They help in the treatment of cancer, diabetes, psoriasis, and rheumatoid arthritis in a highly effective manner.
Biopharmaceuticals have the largest application in the treatment of chronic disorders such as diabetes, autoimmune disorders, cancer, and hematological malignancies is a prime factor that is projected to boost the growth of the global Biopharmaceuticals market in the years to come. Many biopharmaceutical companies are working hard to produce vaccines against the SARS-CoV2 virus. Hence, during the period of the epidemic, this factor is expected to enlarge the growth of the global Biopharmaceuticals market in the coming years. Furthermore, key market players are mainly focusing on the research & development activities for novel product development and approval of newer biopharmaceuticals products are other noteworthy factors that are propelling the growth of the global Biopharmaceuticals market.
However, factors such as complex manufacturing processes, strict government rules, and the high cost of therapy are expected to hamper the growth of the market in the future.
Covid-19 Impact on Biopharmaceutical MarketIn addition, the current Biopharmaceutical Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Biopharmaceutical Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Biopharmaceutical Market Segment OverviewBased on Product, the Monoclonal Antibody segment is expected to lead the global Biopharmaceuticals market. This is because of the widespread use of monoclonal antibodies in therapeutics of chronic disorders and multiple applications in vitro diagnostics. By Application, the Oncology sub-segment is anticipated to lead the therapeutics segment of the market due to the growing prevalence of cancer across the world. Moreover, Retail Pharmacies is the largest segment in the market. A huge number of retail pharmacies coupled with the easy availability of biopharmaceuticals at retail pharmacies is a crucial factor that is projected to boost the segment over the stated period.
Biopharmaceutical Market, By Product
· Monoclonal Antibody
· Vaccines
· Coagulation and growth factors
· Insulin
· Interferons
· Erythropoietin
· Hormones
· Others
Biopharmaceutical Market, By Application
- Therapeutics
- Oncology
- Hematology
- Autoimmune Disorders
- Neurology
- Infectious Disease
- Dermatology
- Gastroenterology
- Orthopedics
- Endocrinology
- Ophthalmology
- Others
- Diagnosis
- Prevention
Biopharmaceutical Market, By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· Diagnostic Laboratories
· Online Pharmacies
Biopharmaceutical Regional OverviewIn terms of region, North America commanded a major share of the global Biopharmaceuticals market and is predictable to maintain its supremacy over the forecast period. Important factors such as the increasing incidence of chronic disorders, growing old age population, and high per capita healthcare expenditure in this region are majorly escalating the growth of the market in North America in the forthcoming years. Similarly, the biopharmaceuticals market in the Asia Pacific is expected to enlarge at a high CAGR in the forecast period. Substantial development of the healthcare sector, easy availability of healthcare facilities, and growing investments in healthcare by leading players in the Asia Pacific are anticipated to enlarge the growth of the market in this region in coming years.
Biopharmaceutical Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Biopharmaceutical Market, Key Players· Abbott Laboratories
· Novo Nordisk A/S
· F. Hoffmann-La Roche AG
· Biogen, Inc.
· Pfizer, Inc.
· Merck & Co., Inc.
· Eli Lilly and Company
· Johnson & Johnson.
· AbbVie, Inc.
· Takeda Pharmaceutical Company Limited
· UCB S.A.
· Serum Institute of India
· Sanofi Aventis AG
· Allergan plc
· Bausch Health Companies Inc.
· Novartis AG
List of Figures
Figure 1: Global Biopharmaceutical Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Biopharmaceutical Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Biopharmaceutical Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Biopharmaceutical Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Biopharmaceutical Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Biopharmaceutical Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Biopharmaceutical Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Biopharmaceutical Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Biopharmaceutical Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Biopharmaceutical Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Biopharmaceutical Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Biopharmaceutical Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Biopharmaceutical Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Biopharmaceutical Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Biopharmaceutical Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Biopharmaceutical Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Biopharmaceutical Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Biopharmaceutical Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Biopharmaceutical Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Biopharmaceutical Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Biopharmaceutical Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Biopharmaceutical Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Biopharmaceutical Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Biopharmaceutical Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Biopharmaceutical Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Biopharmaceutical Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Biopharmaceutical Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Biopharmaceutical Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Biopharmaceutical Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Biopharmaceutical Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Biopharmaceutical Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Biopharmaceutical Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Biopharmaceutical Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Biopharmaceutical Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Biopharmaceutical Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Biopharmaceutical Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Biopharmaceutical Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Biopharmaceutical Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Biopharmaceutical Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Biopharmaceutical Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Research Process
Data Library Research are conducted by industry experts who offer insight on
industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager
and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary Research
Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
